By Dean Seal Federal regulators have lifted a clinical hold on PepGen’s investigational new drug application for a myotonic dystrophy treatment. The…
Markets – MarketWatch
FDA Lifts Hold on PepGen’s New Drug Application for Dystrophy Treatment Markets – MarketWatch
